Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Tune Therapeutics, Inc.

Tune Therapeutics, Inc.

Stage unknownSeattle, WABiotechnology
Facts
Year of incorporation
2020sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Mar 9, 2023
    Form D equity offering · $182M (form d sold) · 39 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Tune Therapeutics, Inc. filed Form D: $182,414,405 sold of $208,045,929, Biotechnology”
Investors on record
1 edges
People
6 officers, 3 directors
Timeline
1
  1. Jan 24, 2025
    Tune Therapeutics, Inc. filed Form D: $182,414,405 sold of $208,045,929, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
17 observations
Every observation on this company